Establishment of treatment regimen to eradicate H. pylori infection in patients who failed 1st-line and 2nd-line therapy.

Establishment of treatment regimen to eradicate H. pylori infection in patients who failed 1st-line and 2nd-line therapy. - Alternative eradicate therapy for H. pylori infection.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013594

Enrollment

100

Registered

2014-04-01

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori-associated gastritis

Interventions

Treat the patients who failed conventinal eradication therapy using sitafloxasin containing regimen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who was diagnosed as infected-with H. pylori

Exclusion criteria

Exclusion criteria: who did not agree

Design outcomes

Primary

Measure	Time frame
eradication rate	—

Secondary

Measure	Time frame
side effects	—

Countries

Japan

Contacts

Public ContactTadashi Shimoyama

Hirosaki University Graduate School of Medicine Gastroenterology

tsimo@hirosaki-u.ac.jp0172-39-5053

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026